Bellevue Group’s Molecular Templates, Inc. MTEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,279,820
| Closed | -$1.8M | – | 176 |
|
|
2024
Q3 | $1.8M | Hold |
1,279,820
| – | – | 0.03% | 108 |
|
|
2024
Q2 | $1.47M | Buy |
1,279,820
+250,000
| +24% | +$370K | 0.02% | 113 |
|
|
2024
Q1 | $2.31M | Hold |
1,029,820
| – | – | 0.04% | 106 |
|
|
2023
Q4 | $3.84M | Sell |
1,029,820
-1,793
| -0.2% | -$9.38K | 0.06% | 100 |
|
|
2023
Q3 | $6.52M | Buy |
1,031,613
+282,946
| +38% | +$2.25M | 0.11% | 98 |
|
|
2023
Q2 | $5.39M | Hold |
748,667
| – | – | 0.08% | 103 |
|
|
2023
Q1 | $4.27M | Sell |
748,667
-3,200
| -0.4% | -$21.6K | 0.06% | 108 |
|
|
2022
Q4 | $3.7M | Hold |
751,867
| – | – | 0.05% | 115 |
|
|
2022
Q3 | $8.46M | Hold |
751,867
| – | – | 0.12% | 101 |
|
|
2022
Q2 | $10.3M | Buy |
751,867
+13,333
| +2% | +$312K | 0.15% | 105 |
|
|
2022
Q1 | $38.2M | Buy |
738,534
+13,334
| +2% | +$589K | 0.44% | 69 |
|
|
2021
Q4 | $42.6M | Hold |
725,200
| – | – | 0.44% | 70 |
|
|
2021
Q3 | $73M | Buy |
725,200
+83,292
| +13% | +$8.59M | 0.74% | 47 |
|
|
2021
Q2 | $75.3M | Buy |
641,908
+98,701
| +18% | +$12.9M | 0.74% | 45 |
|
|
2021
Q1 | $103M | Buy |
543,207
+115,718
| +27% | +$20.3M | 1.09% | 32 |
|
|
2020
Q4 | $60.2M | Buy |
427,489
+92,689
| +28% | +$13.7M | 0.69% | 44 |
|
|
2020
Q3 | $54.8M | Buy |
334,800
+102,984
| +44% | +$18.3M | 0.76% | 40 |
|
|
2020
Q2 | $48M | Buy |
231,816
+37,773
| +19% | +$8.78M | 0.68% | 41 |
|
|
2020
Q1 | $38.7M | Buy |
194,043
+107,664
| +125% | +$23.6M | 0.75% | 37 |
|
|
2019
Q4 | $18.1M | Buy |
+86,379
| New | +$12.4M | 0.29% | 64 |
|
Other funds holding MTEM
Bellevue Group's MTEM Position: Q4 2024 in Review
Bellevue Group sold out of Molecular Templates, Inc. (MTEM) in Q4 2024, closing a stake of 1,279,820 shares — an estimated $1.8M sold.
Bellevue Group first reported a position in MTEM in Q4 2019 and held it in 20 quarters. The position peaked at $103M in Q1 2021. 3 funds tracked by Wall St. Rank hold MTEM as of Q4 2024.
- Bellevue Group reported no remaining Molecular Templates, Inc. position as of Q4 2024 after selling out during the quarter.
- Bellevue Group sold 1,279,820 Molecular Templates, Inc. shares in Q4 2024, an estimated $1.8M.
- Bellevue Group first reported a position in Molecular Templates, Inc. in Q4 2019 and held it in 20 quarters.
- Bellevue Group's Molecular Templates, Inc. position peaked at $103M in Q1 2021.
- 3 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2024.
Based on Bellevue Group's 13F filing for Q4 2024, filed 14 Feb 2025.